Literature DB >> 30088264

Environmental safety: Air pollution while using MIRUS™ for short-term sedation in the ICU.

Jennifer Herzog-Niescery1, Heike Vogelsang1, Philipp Gude1, Hans-Martin Seipp2, Waldemar Uhl3, Thomas P Weber1, Martin Bellgardt1.   

Abstract

BACKGROUND: MIRUS™ is a device for target-controlled inhalational sedation in the ICU in combination with use of isoflurane, or sevoflurane, or desflurane. The feasibility of this device has recently been proven; however, ICU staff exposure may restrict its application. We investigated ICU ambient room pollution during daily work to estimate ICU personnel exposure while using MIRUS™.
METHODS: This observational study assessed pollution levels around 15 adult surgical patients who received volatile anaesthetics-based sedation for a median of 11 hours. Measurements were performed by photoacoustic gas monitoring in real-time at different positions near the patient and in the personnel's breathing zone. Additionally, the impact of the Clean Air™ open reservoir scavenging system on volatile agent pollution was evaluated.
RESULTS: Baseline concentrations [ppm] during intervention and rest periods were isoflurane c ¯ mean = 0.58 ± 0.49, c ¯ max = 5.72; sevoflurane c ¯ mean = 0.22 ± 0.20, c ¯ max = 7.93; and desflurane c ¯ mean = 0.65 ± 0.57, c ¯ max = 6.65. Refilling MIRUS™ with liquid anaesthetic yielded gas concentrations of c ¯ mean = 2.18 ± 1.48 ppm and c ¯ max = 13.03 ± 9.37 ppm in the personnel's breathing zone. Air pollution in the patient's room was approximately five times higher without a scavenging system.
CONCLUSION: Ambient room pollution was minimal in most cases, and the measured values were within or below the recommended exposure limits. Caution should be taken during refilling of the MIRUS™ system, as this was accompanied by higher pollution levels. The combined use of air-conditioning and gas scavenging systems is strongly recommended.
© 2018 The Acta Anaesthesiologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990MIRUSzzm321990; desflurane; enviromental safety; exposure limits; gas pollution; inhalational sedation; intensive care unit; isoflurane; risk reduction; sevoflurane

Mesh:

Substances:

Year:  2018        PMID: 30088264     DOI: 10.1111/aas.13222

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  2 in total

1.  Volatile anesthetics for ICU sedation: the future of critical care or niche therapy?

Authors:  Jeremy R Beitler; Daniel Talmor
Journal:  Intensive Care Med       Date:  2022-09-03       Impact factor: 41.787

2.  Use of MIRUS™ for MAC-driven application of isoflurane, sevoflurane, and desflurane in postoperative ICU patients: a randomized controlled trial.

Authors:  Martin Bellgardt; Adrian Iustin Georgevici; Mitja Klutzny; Dominik Drees; Andreas Meiser; Philipp Gude; Heike Vogelsang; Thomas Peter Weber; Jennifer Herzog-Niescery
Journal:  Ann Intensive Care       Date:  2019-10-16       Impact factor: 6.925

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.